Legence Corp. LGN
52.52
0.07
0.13%
as of 25 Sep
- Market cap
- $5.7B
- P/E
- 0.0×
Follow LGN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+5 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.76 | 1.00 | 1.23 | 1.73 | |
P/FCF ratio |
13.11 | 11.65 | 12.74 | 20.02 | |
P/Operating CF |
18.10 | 26.97 | 31.57 | 87.12 | |
P/B ratio |
2.18 | 3.24 | 3.99 | 6.63 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.03 | 1.24 | 1.48 | 1.93 | |
EV/EBITDA |
12.24 | 15.44 | 20.57 | 32.70 | |
EV/Operating CF |
14.60 | 12.28 | 13.16 | 18.58 | |
EV/FCF |
17.86 | 14.38 | 15.37 | 22.32 | |
Quick Ratio |
1.16 | 1.15 | 0.95 | 0.99 | |
Current Ratio |
1.57 | 1.57 | 1.30 | 1.35 | |
Net Debt/EBITDA |
9.95 | 19.56 | 12.03 | 12.46 | |
Debt/Assets |
31.88% | 30.94% | 29.49% | 27.66% | |
Debt/Equity |
1.00 | 1.05 | 1.08 | 1.06 | |
Asset Turnover |
1.83 | 1.90 | 1.77 | 2.00 | |
Operating CF/Net income |
(172.89) | (2.90) | 7.46 | (2.67) | |
Capex/Depreciation |
(0.37) | (0.24) | (0.41) | (0.36) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.13% | 15.56% | 11.19% | 11.69% | |
Intangible Assets out of Total Assets |
0.52 | 0.49 | 0.48 | 0.43 | |
Share Based Compensation of Revenue |
2.63% | 6.19% | 3.53% | 5.97% | |
Graham Net Nets |
(0.41) | (0.31) | (0.28) | (0.17) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(0.79%) | (0.79%) | (0.79%) | (0.79%) | |
Free Cash Flow Yield |
7.63% | 8.58% | 7.85% | 4.99% | |
Revenue per Share |
12.10 | 12.42 | 15.46 | 16.60 | |
Operating CF per Share |
1.70 | 1.60 | 1.79 | 0.98 | |
Capex per Share |
(0.18) | (0.22) | (0.26) | (0.32) | |
Free Cash Flow per Share |
1.52 | 1.38 | 1.53 | 0.66 | |
Cash per Share |
3.01 | 3.88 | 3.64 | 3.84 | |
Shareholders Equity per Share |
14.14 | 13.28 | 14.16 | 12.86 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
14.14 | 13.28 | 14.16 | 12.86 | |
Free Cash Flow |
89.07 | 81.71 | 102.42 | 50.42 | |
Working Capital |
377.81 | 402.19 | 337.19 | 423.51 | |
Capital Expenditures |
(10.51) | (13.04) | (17.69) | (23.96) | |
Net Current Asset Value |
(734.99) | (780.25) | (1,061.47) | (1,113.97) | |
EV/EBIT |
21.92 | 51.23 | 67.87 | 245.27 | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
(0.08%) | (4.44%) | 1.55% | (2.21%) | |
Price to Operating Income |
16.09 | 41.50 | 56.26 | 220.06 | |
| Other line items | |||||
Average Receivables |
— | — | — | 683.77 | |
Average Payables |
— | — | — | 277.75 | |
Average Assets |
1,300.13 | 1,339.70 | 1,741.55 | 1,869.84 | |
Average Common Equity |
— | — | — | 590.57 |
Columns are period end dates